Ismaheel O. Lawal

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Mike Sathekge, Frank Bruchertseifer, Otto Knoesen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 344 citations · Full text

Medicine, Oncology, Pharmacology +17

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving ²²⁵Ac-PSMA-617 Radioligand Therapy

Mike Sathekge, Frank Bruchertseifer, Mariza Vorster et al. · Journal of Nuclear Medicine · 2019 · 194 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study

Mike Sathekge, Ismaheel O. Lawal, Chandrasekhar Bal et al. · The Lancet Oncology · 2024 · 178 citations

Medicine, Oncology, Urology +17

Intraindividual Comparison of ¹⁸F-PSMA-1007 and ¹⁸F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study

Frederik L. Giesel, Leon Will, Ismaheel O. Lawal et al. · Journal of Nuclear Medicine · 2017 · 176 citations · Full text

Medicine, Oncology, Radiation Oncology +17

68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?

Thabo Lengana, Ismaheel O. Lawal, Tebatso Boshomane et al. · Clinical Genitourinary Cancer · 2018 · 121 citations

Medicine, Nuclear Medicine, Oncology +17